These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29991292)

  • 1. Synthesis and evaluation of coumarin/1,2,4-oxadiazole hybrids as selective BChE inhibitors with neuroprotective activity.
    Zhang J; Li JC; Song JL; Cheng ZQ; Sun JZ; Jiang CS
    J Asian Nat Prod Res; 2019 Nov; 21(11):1090-1103. PubMed ID: 29991292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
    Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
    Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking.
    Lima JA; R Costa TW; da Fonseca ACC; do Amaral RF; Nascimento MDDSB; Santos-Filho OA; de Miranda ALP; Ferreira Neto DC; Lima FRS; Hamerski L; Tinoco LW
    Bioorg Chem; 2020 Nov; 104():104215. PubMed ID: 32920358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
    Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY
    Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrine-coumarin and Tacrine-7-chloroquinoline Hybrids with Thiourea Linkers: Cholinesterase Inhibition Properties, Kinetic Study, Molecular Docking and Permeability Assay for Blood-brain Barrier.
    Hamulakova S; Janovec L; Soukup O; Jun D; Janockova J; Hrabinova M; Sepsova V; Kuca K
    Curr Alzheimer Res; 2018; 15(12):1096-1105. PubMed ID: 29992880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
    Xie SS; Wang XB; Li JY; Yang L; Kong LY
    Eur J Med Chem; 2013 Jun; 64():540-53. PubMed ID: 23685572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural modification and biological evaluation of tetrahydrothienopyridine derivatives as selective BChE inhibitors.
    Chen T; Sang S; Wei Y; Ge Y; Jin J; Bian Y; Pei Y; Li N; Sun H; Chen Y
    Bioorg Med Chem Lett; 2023 Sep; 93():129436. PubMed ID: 37549853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in Vitro Cholinesterase Inhibition, Molecular Docking, DFT, and ADME Studies of Novel 1,3,4-Oxadiazole-2-Thiol Derivatives.
    Tariq S; Mutahir S; Khan MA; Mutahir Z; Hussain S; Ashraf M; Bao X; Zhou B; Stark CBW; Khan IU
    Chem Biodivers; 2022 Aug; 19(8):e202200157. PubMed ID: 35767725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Xie SS; Lan JS; Wang X; Wang ZM; Jiang N; Li F; Wu JJ; Wang J; Kong LY
    Bioorg Med Chem; 2016 Apr; 24(7):1528-39. PubMed ID: 26917219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Molecular Hybrids of
    Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
    ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
    Saeed A; Zaib S; Ashraf S; Iftikhar J; Muddassar M; Zhang KY; Iqbal J
    Bioorg Chem; 2015 Dec; 63():58-63. PubMed ID: 26440714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
    Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
    Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T
    Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation.
    He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS
    Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
    Sun Q; Peng DY; Yang SG; Zhu XL; Yang WC; Yang GF
    Bioorg Med Chem; 2014 Sep; 22(17):4784-91. PubMed ID: 25088549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.